# Honeywell — Hazardous Materials Safety Interpretation

**Citation:** 01-0214  
**Type / status:** guidance / guidance  
**Agency:** Pipeline and Hazardous Materials Safety Administration  
**Effective:** Not stated  
**Published:** 2001-10-19

01-0214 response to Honeywell concerning 173.134.

## Document text

<<<PAGE 1>>>

of Transportation
U.S. Department
Washington, D.C. 20590
400 Seventh St., S.W.
Research and
Special Programs
Administration
OCT 19 2001
Ms. Barbara Konrad
Ref. No. 01-0214
Manager, Transportation Regulatory Affairs
Honeywell
P.O. Box 10957
Morristown, NJ 07962-1057
Dear Ms. Konrad:
This is in response to your letter asking if the aerospace equipment contaminated with blood and
human remains that your company collects from accident sites is regulated as an infectious
substance under the Hazardous Materials Regulations (HMR; 49 CFR Parts 171-180). You
stated that your company has no reason to believe these items meet the definition in § 173.134
for an infectious substance.
Your understanding is correct. Provided the aerospace equipment is not contaminated with other
material within the aircraft that meets the definition of an infectious substance, such as an
infectious substance package that has released its contents, it would not be regulated under the
HMR.
I hope this satisfies your request.
Sincerely,
Sour Guts
Transportation Regulations Specialist
Office of Hazardous Materials Standard:
010214
-

<<<PAGE 2>>>

Honeywell
Honeywell
Edmonson
P.O. Box 1057
Morristown, NJ 07962-1057
$173.134
Classification
01-0214
August 14, 2001
Research and Special Programs Administration
Office of Hazardous Materials Standards (DHM-10)
US Department of Transportation
400 Seventh Street SW
Washington, DC 20590-0001
Subject:
Interpretation on Infectious Substance Classification
Equipment Contaminated With Human Remains
Dear Sir or Madam:
After an aircraft accident, Honeywell International teams are sometimes deployed to crash
in the wreck. Some pieces of equipment are contaminated with blood and/or pieces of human
sites to collect, package and ship Honeywell aerospace components and equipment damaged
remains.
We believe these shipments do not meet the DOT definition of infectious substance (class
6.2) under 49 CFR 173.134.
We base our conclusion on the following facts: (1) We have no reason to believe or suspect
no reason to suspect that any of the blood or remains contained any agent listed in 42 CFR
that the blood or remains would cause any severe, disabling or fatal disease; (2) We have
remains were certainly not prepared or manufactured in accordance with 9 CFR or 21 CFR
72.3; (3) We are not shipping the blood / remains for diagnostic purposes; (4) The blood /
regarding biologic or drug products; and (5) the blood / remains are not regulated medical
waste since they were not generated in any of the means listed in 49 CFR 173.134 (a)(4).
body part destined for interment or cremation) but believe these materials do not meet the
We do not see any specific exception for blood or human remains (other than for a corpse or
definition of class 6.2 under DOT rules and the equipment contaminated with this material can
therefore be shipped "not regulated".
Please let us know if you concur with our assessment of this situation.
Sincerely,
Bahuakomal
no 113-465.200
Barbara Konrad
Manager, Transportation Regulatory Affairs

## Provenance

- Official: Yes
- Source: <https://www.phmsa.dot.gov/sites/phmsa.dot.gov/files/legacy/interpretations/Interpretation%20Files/2001/010214.pdf>
- Source ID: `phmsa`
- SHA-256: `fe5728bfd527e0a50a14e67b9dde02c419fa96721301ca08ebc011701bc2b7e4`
- Retrieved: 2026-08-20T00:59:31.977Z
- Exported: 2026-08-22T17:50:01.086Z
- Document slug: `phmsa-interpretation-01-0214`

### Source metadata

```json
{
  "materialSubtype": "interpretation",
  "interpretationArea": "hazardous_materials",
  "representation": "full_text_from_official_pdf",
  "companies": [
    "Honeywell"
  ],
  "individuals": [
    "Ms. Barbara Konrad"
  ],
  "refIds": [
    "01-0214"
  ],
  "catalogDates": [
    "2001-10-19"
  ],
  "catalogParts": [
    173
  ],
  "catalogRowCount": 1,
  "sourceRecordUrls": [
    "https://www.phmsa.dot.gov/node/66711"
  ],
  "linkedAttachmentUrls": [],
  "unavailableResponseUrls": [],
  "duplicateRepresentationUrls": [],
  "citedSections": [
    "173.134"
  ],
  "catalogPageUrls": [
    "https://www.phmsa.dot.gov/regulations/title49/section/173134"
  ],
  "pdfUrls": [
    "https://www.phmsa.dot.gov/sites/phmsa.dot.gov/files/legacy/interpretations/Interpretation%20Files/2001/010214.pdf"
  ],
  "representations": [
    {
      "viewUrl": "https://www.phmsa.dot.gov/sites/phmsa.dot.gov/files/legacy/interpretations/Interpretation%20Files/2001/010214.pdf",
      "detailUrl": null,
      "detailHtmlPath": null,
      "pdfUrl": "https://www.phmsa.dot.gov/sites/phmsa.dot.gov/files/legacy/interpretations/Interpretation%20Files/2001/010214.pdf",
      "pdfArtifactPath": "data/sources/phmsa-interpretations/01-0214-ebb1b19eac.pdf",
      "pdfArtifactSha256": "9c63302fc5557b7ad39639fa97a8515b6a658b8abc5077c6ea9bc71548927b93",
      "extractedTextPath": "data/sources/phmsa-interpretations/01-0214-ebb1b19eac.v2.txt",
      "extractedTextSha256": "4676f882517b6721bc48ec9027f1a2ab1189fd916a9acac2ed9bbc8c5157becc",
      "pageCount": 2,
      "extractionVersion": 2
    }
  ],
  "caveat": "Interpretations apply regulations to the facts presented and do not create independently enforceable requirements.",
  "jurisdiction": "US"
}
```